Abstract
The pharmaceutical industry mainly uses cellular assays to assess drug effectiveness, yet this doesn’t provide information about the effects on neuronal communication, which is disrupted in neurodegenerative diseases. Researchers in the NEUREKA project are developing a novel drug screening system which could facilitate the drug discovery process for neurodegenerative diseases, as Dr Yiota Poirazi explains.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: EU Research - The necessity of science in uncertain times
Paper Title
Journal
Date
